About this trial
Breast cancer is one of the most common types of cancer among women and one of the leading causes of morbidity and mortality. With increasing survival rates, issues such as treatment-related morbidities and consequently upper extremity dysfunction, reduced body awareness, and decreased quality of life are frequently encountered. In the literature, the impact of treatment-related morbidities-particularly on upper extremity functions, body awareness, and quality of life-among women who have survived breast cancer treatment has not been sufficiently investigated. This gap constitutes a significant shortcoming in terms of clinical practices and the post-treatment period.
This study aims to examine the effects of breast cancer treatment on upper extremity functions, body awareness, and quality of life in women who have survived breast cancer treatment, in comparison with a healthy control group. The study will be conducted at Yeditepe University Koşuyolu Hospital between May, 2025, and October, 2025. Participants will include women who have survived breast cancer treatment and a healthy control group matched based on criteria such as age and body mass index.
In the study, three separate assessments will be conducted for upper extremity functions: the "Quick Disabilities of the Arm, Shoulder, and Hand" (QuickDASH) questionnaire for upper extremity functionality, a hand dynamometer for grip strength, and the Clinometer device for shoulder joint position sense. The "Body Awareness Questionnaire" will be used to assess body awareness, and the "EORTC QLQ-C30" scale will be used for quality of life assessment. The IBM SPSS Statistics software package will be used for data analysis. In statistical analyses, a significance level of p\<0.05 will be considered.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Being a woman
Being between the ages of 25 and 75
Having been diagnosed with Stage 0-III breast cancer
Having completed primary treatments (surgery, chemotherapy, and/or radiation therapy) no more than 6 months prior to the assessment date
Disqualifiers
Having a history of rehabilitation due to upper extremity, thoracic, or cervical musculoskeletal disorders within 6 months prior to the breast cancer diagnosis
Having a history of neuromuscular dysfunction
Using medications that may affect neuromuscular performance
Being a woman
Trial population
The study population consists of women who have survived breast cancer treatment at Yeditepe University Koşuyolu Hospital and a healthy control group. The sample will include breast cancer survivors and healthy controls who meet the inclusion and exclusion criteria and voluntarily agree to participate in the study.
Trial design
Case-control
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Body Awareness Scale
The scale consists of 18 items evaluated on a 7-point Likert scale and aims to determine the sensitivity level of body composition through 4 subgroups. The four sub-parameters of the scale are: "Changes in Body Processes," "Sleep-Wake Cycle," "Prediction of Illness Onset," and "Prediction of Bodily Reactions."
Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire
The questionnaire will be used to determine individuals' levels of functionality.
Hand Grip Strength Assessment
A Jamar Hand Dynamometer (Takei Scientific Instruments Co., Ltd - Japan) will be used to measure participants' maximum grip strength
Shoulder Joint Position Sense
Shoulder joint position sense will be assessed using the "Clinometer" smartphone application. Goniometer and inclinometer applications, adapted for both iOS and Android systems, are low-cost methods with proven validity and reliability, accessible to a wide population
Sponsors and contacts
Click on the lead sponsor to view all of their trials.